
Getting serious about women’s heart health
Women experiencing chest pain or other symptoms of cardiac distress now have access to a specialist clinic just for them.
COVID-19: Everything you need to know about patient and visitor information.
In the Department of Cardiology, we maintain a heavy academic interest in improving the lives of our patients through careful research and scientific study.
We offer a range of diagnostic tests and treatments that are not offered anywhere else, and focus on ensuring that patients are offered the utmost in advances in recent evidence based medicine. The Alfred co-ordinates several large international research trials while also running focused tailored trials for patients, offering close clinical contact and access to cutting edge research.
We have a number of collaborative studies with Baker Heart & Diabetes Institute, the Burnet Institute and other Alfred Health services including:
Several distinguished members of the department have published in the key academic journals in cardiology, from the American Heart Association, American College of Cardiology and European Society of Cardiology.
We firmly believe in patient-centred care, and offering the latest that research has to offer is part of that.
Elizabeth Davida Paratz, Luke Rowsell, Dominica Zentner, Sarah Parsons, Natalie Morgan, Tina Thompson, Paul James, Andreas Pflaumer, Christopher Semsarian, Karen Smith, Dion Stub, Andre La Gerche,
(2020), Open heart, 7(1), e001195
Shane Nanayakkara, Melissa Byrne, Vivian Mak, Kaye Carter, Eliza Dean, David M Kaye
(2020), J AM HEART ASSOC, 9(13), e015026
Edward J Quine, Misha Dagan, Jeremy William, Shane Nanayakkara, Luke P Dawson, Stephen J Duffy, Julia Stehli, Ron J Dick, Nay M Htun, Dion Stub, Antony S Walton
(2020), AM J CARDIOL, 137, 77-82
Women experiencing chest pain or other symptoms of cardiac distress now have access to a specialist clinic just for them.
Drinking coffee could help you live longer according to world-first research by heart specialists at The Alfred.
A ground-breaking trial taking place across Australia and New Zealand could change the future of heart transplantation, potentially enabling up to 15 per cent more heart transplants to occur each year.